CM
Chris Mynhard Botha
About Chris Mynhard Botha
Data last updated:
Chris Mynhard Botha is a Director at Alphamed Formulations Private Limited (since 2023). The company operates in Pharma. Alphamed Formulations Private Limited reported revenue of ₹197 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 13 Oct 2023 | 2006 | ₹197 Cr (FY 2025) | Active |
Board colleagues of Chris Mynhard Botha
| Name | DIN | Company | Designation |
|---|---|---|---|
| Lorraine Angela Hill | 02337226 | Alphamed Formulations Private Limited | Director |
| Ramesh Cheruvu | 07649475 | Alphamed Formulations Private Limited | Whole-Time Director |
| Sudheer Reddy Gundu | Alphamed Formulations Private Limited | Company Secretary |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Chris Mynhard Botha
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Chris Mynhard Botha
Chris Mynhard Botha currently holds 1 directorship: Alphamed Formulations Private Limited (Director, since 13 Oct 2023, revenue ₹197 Cr (FY 2025)).
Chris Mynhard Botha was first appointed on 13 Oct 2023 as Director at Alphamed Formulations Private Limited.
The current boards of Chris Mynhard Botha's companies include Lorraine Angela Hill (Alphamed Formulations Private Limited), Ramesh Cheruvu (Alphamed Formulations Private Limited), Sudheer Reddy Gundu (Alphamed Formulations Private Limited).